The Asia Pacific Psychiatric Digital Biomarkers Market would witness market growth of 25.3% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Psychiatric Digital Biomarkers Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $162.9 million by 2031. The Japan market is experiencing a CAGR of 24.5% during (2024 - 2031). Additionally, The India market would exhibit a CAGR of 26.1% during (2024 - 2031).
Machine learning enhances these applications by enabling predictive analytics, such as forecasting relapse risks in chronic conditions like bipolar disorder. For example, irregular sleep patterns, reduced physical activity, and heart rate variability changes could signal an impending manic or depressive episode, prompting timely clinical intervention. ML models continuously refine their accuracy by learning from new data, making them highly effective for personalized care.2 para overviews
India also faces significant mental health challenges, with epidemiological studies reporting prevalence rates ranging from 9.5 to 370 per 1,000 people. Common disorders include depression, anxiety, bipolar disorder, schizophrenia, and substance use disorders. The mental health burden in India is immense, with 2,443 disability-adjusted life years (DALYs) per 10,000 population and an age-adjusted suicide rate of 21.1 per 100,000 population. Additionally, the economic cost of mental health issues in India from 2012 to 2030 is estimated to be USD 1.03 trillion, emphasizing the urgent need for effective interventions and support systems. Consequently, digital biomarkers can be instrumental in the improvement of regional outcomes and the bridging of care disparities by facilitating the early detection and monitoring of mental health conditions.
Free Valuable Insights: The Global Psychiatric Digital Biomarkers Market is Predict to reach USD 2.78 Billion by 2031, at a CAGR of 24.1%
Based on Type, the market is segmented into Wearable, Mobile based Applications, Sensors, and Other Type. Based on Clinical Practice, the market is segmented into Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive and Prognostic Psychiatric Digital Biomarkers, and Other Clinical Practice. Based on End Use, the market is segmented into Healthcare Companies, Healthcare Providers, Payers, and Other End Use. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
By Type
By Clinical Practice
By End Use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 